Issued Patents 2019
Showing 1–8 of 8 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 10517866 | Removing senescent cells from a mixed cell population or tissue using a phosphoinositide 3-kinase (PI3K) inhibitor | Remi-Martin Laberge, James L. Kirkland, Tamar Tchkonia, Yi Zhu, Nathaniel David +3 more | 2019-12-31 |
| 10478432 | Compositions of matter for treatment of ophthalmic conditions by selectively removing senescent cells from the eye | Remi-Martin Laberge, Judith Campisi, Marco Demaria, Nathaniel David, Alain P. Vasserot +5 more | 2019-11-19 |
| 10478433 | Unit dose of an aryl sulfonamide that is effective for treating eye disease and averting potential vision loss | Remi-Martin Laberge, Judith Campisi, Marco Demaria, Nathaniel David, James L. Kirkland +5 more | 2019-11-19 |
| 10413542 | Methods and compositions for killing senescent cells and for treating senescence-associated diseases and disorders using an inhibitor of Akt kinase | Remi-Martin Laberge, Nathaniel David, Alain P. Vasserot, Bennett G. Childs, James L. Kirkland +3 more | 2019-09-17 |
| 10328073 | Use of sulfonamide inhibitors of BCL-2 and BCL-xL to treat ophthalmic disease by selectively removing senescent cells | Remi-Martin Laberge, Judith Campisi, Marco Demaria, Nathaniel David, Alain P. Vasserot +5 more | 2019-06-25 |
| 10328058 | Treating atherosclerosis by removing senescent foam cell macrophages from atherosclerotic plaques | Marco Demaria, Albert Davalos, Bennett G. Childs, Jan M.A. van Deursen, James L. Kirkland +5 more | 2019-06-25 |
| 10258618 | Treating pulmonary conditions by selectively removing senescent cells from the lung using an intermittent dosing regimen | Remi-Martin Laberge, Judith Campisi, Marco Demaria, Nathaniel David, James L. Kirkland +3 more | 2019-04-16 |
| 10251376 | Increasing healthy lifespan and delaying progression of age-related phenotypes by selectively removing senescent cells | James L. Kirkland, Tamar Tchkonia, Jan M.A. van Deursen | 2019-04-09 |